cobra-cardiotoxin-proteins and Myositis

cobra-cardiotoxin-proteins has been researched along with Myositis* in 3 studies

Other Studies

3 other study(ies) available for cobra-cardiotoxin-proteins and Myositis

ArticleYear
PGC-1α modulates necrosis, inflammatory response, and fibrotic tissue formation in injured skeletal muscle.
    Skeletal muscle, 2016, Volume: 6

    Skeletal muscle tissue has an enormous regenerative capacity that is instrumental for a successful defense against muscle injury and wasting. The peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) exerts therapeutic effects in several muscle pathologies, but its role in damage-induced muscle regeneration is unclear.. Using muscle-specific gain- and loss-of-function models for PGC-1α in combination with the myotoxic agent cardiotoxin (CTX), we explored the role of this transcriptional coactivator in muscle damage and inflammation.. Interestingly, we observed PGC-1α-dependent effects at the early stages of regeneration, in particular regarding macrophage accumulation and polarization from the pro-inflammatory M1 to the anti-inflammatory M2 type, a faster resolution of necrosis and protection against the development of fibrosis after multiple CTX-induced injuries.. PGC-1α exerts beneficial effects on muscle inflammation that might contribute to the therapeutic effects of elevated muscle PGC-1α in different models of muscle wasting.

    Topics: Animals; Cobra Cardiotoxin Proteins; Fibrosis; Gene Expression; Hydroxyproline; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Contraction; Muscle, Skeletal; Myositis; Necrosis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Regeneration

2016
Delayed angiogenesis and VEGF production in CCR2-/- mice during impaired skeletal muscle regeneration.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2007, Volume: 293, Issue:2

    The regulation of vascular endothelial growth factor (VEGF) levels and angiogenic events during skeletal muscle regeneration remains largely unknown. This study examined angiogenesis, VEGF levels, and muscle regeneration after cardiotoxin (CT)-induced injury in mice lacking the CC chemokine receptor 2 (CCR2). Muscle regeneration was significantly decreased in CCR2-/- mice as was the early accumulation of macrophages after injury. In both mouse strains, tissue VEGF was similar at baseline (no injections) and significantly decreased at day 3 post-CT. Tissue VEGF in wild-type (WT) mice was restored within 7 days postinjury but remained significantly reduced in CCR2-/- mice until day 21. Capillary density (capillaries/mm(2)) within regenerating muscle was maximal in WT mice at day 7 and double that of baseline muscle. In comparison, maximal capillary density in CCR2-/- mice occurred at 21 days postinjury. Maximal capillary density developed concurrent with the restoration of tissue VEGF in both strains. A highly significant, inverse relationship existed between the size of regenerated muscle fibers and capillaries per square millimeter. Although this relationship was comparable in WT and CCR2-/- animals, there was a significant decrease in the magnitude of this response in the absence of CCR2, reflecting the observation that regenerated muscle fiber size in CCR2-/- mice was only 50% of baseline at 42 days postinjury, whereas WT mice had attained baseline fiber size by day 21. Thus CCR2-dependent events in injured skeletal muscle, including impaired macrophage recruitment, contribute to restoration of tissue VEGF levels and the dynamic processes of capillary formation and muscle regeneration.

    Topics: Adipose Tissue; Animals; Capillaries; Chemokine CCL2; Cobra Cardiotoxin Proteins; Female; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Muscle Fibers, Skeletal; Muscle Proteins; Muscle, Skeletal; Myositis; Neovascularization, Physiologic; Organ Size; Receptors, CCR2; Receptors, Chemokine; Regeneration; Vascular Endothelial Growth Factor A

2007
The urokinase-type plasminogen activator receptor is not required for skeletal muscle inflammation or regeneration.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2007, Volume: 293, Issue:3

    The hypothesis of this study was the urokinase-type plasminogen activator receptor (uPAR) is required for accumulation of inflammatory cells in injured skeletal muscle and for efficient muscle regeneration. Expression of uPAR was elevated at 1 and 3 days after cardiotoxin-induced muscle injury in wild-type mice before returning to baseline levels. Neutrophil accumulation peaked 1 day postinjury in muscle from both wild-type (WT) and uPAR null mice, while macrophage accumulation peaked between 3 and 5 days postinjury, with no differences between strains. Histological analyses confirmed efficient muscle regeneration in both wild-type and uPAR null mice, with no difference between strains in the formation or growth of regenerating fibers, or recovery of normal morphology. Furthermore, in vitro experiments demonstrated that chemotaxis is not different between WT and uPAR null macrophages. Finally, fusion of cultured satellite cells into multinucleated myotubes was not different between cells isolated from WT and uPAR null mice. These results demonstrate that uPAR is not required for the accumulation of inflammatory cells or the regeneration of skeletal muscle following injury, suggesting uPA can act independently of uPAR to regulate events critical for muscle regeneration.

    Topics: Animals; Antibodies, Blocking; Cell Fusion; Cell Movement; Cells, Cultured; Chemotaxis; Cobra Cardiotoxin Proteins; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Myositis; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Regeneration; Reverse Transcriptase Polymerase Chain Reaction; Satellite Cells, Skeletal Muscle

2007